Spiro, A S <br/><br/>
Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series.  [electronic resource] 

 -  The Journal of bone and joint surgery. British volume  May 2011 
 - 695-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>2044-5377 
<br/><br/><label>Standard No.: </label>10.1302/0301-620X.93B5.25938  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ankle Joint--physiopathology<br/>Bone Morphogenetic Protein 2<br/>Bone Morphogenetic Proteins--therapeutic use<br/>Child, Preschool<br/>Combined Modality Therapy<br/>External Fixators<br/>Female<br/>Follow-Up Studies<br/>Fracture Fixation, Intramedullary--methods<br/>Fracture Healing--drug effects<br/>Humans<br/>Ilizarov Technique<br/>Knee Joint--physiopathology<br/>Male<br/>Pseudarthrosis--congenital<br/>Radiography<br/>Range of Motion, Articular<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Tibial Fractures--diagnostic imaging<br/>Transforming Growth Factor beta--therapeutic use<br/>Treatment Outcome<br/>Young Adult